Filana Therapeutics
FLNA
#10417
Rank
A$58.12 M
Marketcap
A$1.20
Share price
-4.53%
Change (1 day)
-65.45%
Change (1 year)

Earnings for Filana Therapeutics (FLNA)

Earnings in 2026 (TTM): -A$69 Million

According to Filana Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.14 Billion, an increase over its 2024 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Filana Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$69 Million-48.85%
2025 -A$0.14 Billion-32.44%
2024 -A$0.2 Billion34.28%
2023 -A$0.15 Billion32.41%
2022 -A$0.12 Billion143.46%
2021 -A$46.13 Million383.92%
2020 -A$9.54 Million36.96%
2019 -A$6.96 Million-25.56%
2018 -A$9.35 Million-44.25%
2017 -A$16.77 Million-20.11%
2016 -A$21 Million5.32%
2015 -A$19.94 Million14.23%
2014 -A$17.45 Million-139.64%
2013 A$44.01 M
2010 -A$19.23 Million102.87%
2009 -A$9.48 Million-177.52%
2008 A$12.22 M-14.32%
2007 A$14.27 M-1942.21%
2006 -A$0.78 Million
2004 -A$54.68 Million75.1%
2003 -A$31.23 Million
2001 -A$24.3 Million20.49%
2000 -A$20.17 Million